BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 13278240)

  • 1. The parasitic growth of Claviceps purpurea (Fries) Tulasne on rye and its relation to alkaloid formation.
    RAMSTAD E; GJERSTAD G
    J Am Pharm Assoc Am Pharm Assoc; 1955 Dec; 44(12):741-3. PubMed ID: 13278240
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of certain chemicals on the growth and alkaloid formation of Claviceps purpurea (Fries) Tulasne in artificial culture.
    GJERSTAD G; RAMSTAD E
    J Am Pharm Assoc Am Pharm Assoc; 1955 Dec; 44(12):736-40. PubMed ID: 13278239
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of certain rye homogenates for supporting growth of Claviceps purpurea (Fries) Tulasne.
    BERMAN ML; YOUNGKEN HW
    J Am Pharm Assoc Am Pharm Assoc; 1954 Apr; 43(4):200-4. PubMed ID: 13151977
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of alkaloid formation of Claviceps purpurea in parasitic and saprophytic cultures].
    KOBEL H; BRUNNER R; BRACK A
    Experientia; 1962 Mar; 18():140-1. PubMed ID: 14457494
    [No Abstract]   [Full Text] [Related]  

  • 5. [Problems of species and strains of the ergot Claviceps purpurea Tulasne].
    KYBAL J; BREJCHA V
    Pharmazie; 1955 Dec; 10(12):752-5. PubMed ID: 13310248
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recent chemical research on the alkaloids of ergot of rye].
    STOLL A
    Farmaco Sci Tec; 1951; 6(4):475-94. PubMed ID: 14872881
    [No Abstract]   [Full Text] [Related]  

  • 7. [Poisoning by the ergot of rye. (One of its alkaloids: ergonovine)].
    SASTRE MACEDO M; ORTEGA CL; HEPNER M
    Dia Med; 1960 May; 32():861. PubMed ID: 14441885
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the content of alkaloids in domestic wild rye ergot].
    TROPP MIa; SINILOVA NG
    Med Prom SSSR; 1961 Aug; 8():10-4. PubMed ID: 14039807
    [No Abstract]   [Full Text] [Related]  

  • 9. A note on the metabolism of lysergic acid by Claviceps purpurea (Fries) Tulasne.
    GJERSTAD G
    J Am Pharm Assoc Am Pharm Assoc; 1956 Jun; 45(6):428-30. PubMed ID: 13319156
    [No Abstract]   [Full Text] [Related]  

  • 10. [CULTIVATION OF ERGOT ORGANISMS ON DIFFERENT HOSTS. I. CULTIVATION OF DIFFERENT STRAINS OF CLAVICEPS MICROCEPHALA (WALLR.) TUL. AND CLAVICEPS PURPUREA (FR) TUL. ON VARIETIES OF WHEAT, BARLEY AND RYE].
    YANG YP; YUEH TC; LU SI
    Yao Xue Xue Bao; 1964 May; 11():305-11. PubMed ID: 14181131
    [No Abstract]   [Full Text] [Related]  

  • 11. [Some recent developments on the pharmacology of ergot of rye].
    ROTHLIN E; FANCHAMPS A
    Rev Pathol Gen Physiol Clin; 1955 Dec; 55(673):1427-43. PubMed ID: 13298391
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypothermic neuroplegia, called artificial hibernation, with dihydrogenated derivatives of ergot of rye; physiological study].
    CAHN J; MELON JM; DUBRASQUET ; BODIOU
    Anesth Anal; 1954 Oct; 11(3):513-32. PubMed ID: 15444698
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ergot cultivation on tetraploid rye].
    DEUFEL J
    Arch Pharm Ber Dtsch Pharm Ges; 1954; 287(6):329-32. PubMed ID: 13198207
    [No Abstract]   [Full Text] [Related]  

  • 14. Evolution of the Ergot Alkaloid Biosynthetic Gene Cluster Results in Divergent Mycotoxin Profiles in
    Hicks C; Witte TE; Sproule A; Lee T; Shoukouhi P; Popovic Z; Menzies JG; Boddy CN; Liu M; Overy DP
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the Ergot Alkaloid and Indole Diterpenoid Metabolome in the
    Uhlig S; Rangel-Huerta OD; Divon HH; Rolén E; Pauchon K; Sumarah MW; Vrålstad T; Renaud JB
    J Agric Food Chem; 2021 Jun; 69(25):7137-7148. PubMed ID: 34148344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PRIMARY DYSMENORRHEA. TRIAL TREATMENT WITH A DERIVATIVE OF RYE ERGOT].
    CHABRIER J; BARRIER J
    Rev Fr Gynecol Obstet; 1964; 59():345-53. PubMed ID: 14169676
    [No Abstract]   [Full Text] [Related]  

  • 17. [Variability of alkaloid content of Claviceps purpurea in Oberlausitz, Germany].
    SCHULZE T
    Pharmazie; 1953 May; 8(5):412-6. PubMed ID: 13088284
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contributions on saprophytic culture of Claviceps purpurea Tul. in connection with alkaloid formation].
    KAISER H; THIELMANN E
    Arch Pharm Ber Dtsch Pharm Ges; 1956 Jul; 289/61(7):378-87. PubMed ID: 13340915
    [No Abstract]   [Full Text] [Related]  

  • 19. Covariation of Ergot Severity and Alkaloid Content Measured by HPLC and One ELISA Method in Inoculated Winter Rye across Three Isolates and Three European Countries.
    Kodisch A; Oberforster M; Raditschnig A; Rodemann B; Tratwal A; Danielewicz J; Korbas M; Schmiedchen B; Eifler J; Gordillo A; Siekmann D; Fromme FJ; Wuppermann FN; Wieser F; Zechner E; Niewińska M; Miedaner T
    Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33114663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the nervous system in sympatholytic action of Claviceps purpurea alkaloids].
    FALL S; KELEMAN A; OBAL F
    Acta Physiol Acad Sci Hung; 1955; 7(3):223-7. PubMed ID: 13248576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.